Company Filing History:
Years Active: 2002-2003
Title: Grayland Page Dobson: Innovator in Central Nervous System Treatments
Introduction
Grayland Page Dobson is a notable inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders. With a total of five patents to his name, Dobson's work has the potential to impact many lives.
Latest Patents
Dobson's latest patents include innovative compounds designed for patients suffering from central nervous system disorders. One of his notable inventions is a class of 3-pyridinyl compounds, which are effective in treating these conditions. A representative compound from this patent is (E)-N-methyl-5-(3-pyridinyl)-4-penten-2-amine. Additionally, he has developed pyrimidinyl compounds that also target central nervous system disorders, utilizing similar aryl substituted amine compounds.
Career Highlights
Grayland Page Dobson is currently associated with Targacept, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective treatments that can improve the quality of life for patients with neurological issues.
Collaborations
Throughout his career, Dobson has collaborated with esteemed colleagues, including Gary Maurice Dull and William Scott Caldwell. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion
Grayland Page Dobson is a prominent figure in the realm of pharmaceutical inventions, particularly in the treatment of central nervous system disorders. His contributions through patents and collaborations highlight his commitment to advancing medical science.